Source: Journal of Clinical Oncology. Unidade: FMRP
Subjects: CRIANÇAS, LEUCEMIA (TRATAMENTO)
ABNT
BRANDALISE, Silvia R. et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology, v. 28, n. 11, p. 1911-1918, 2010Tradução . . Acesso em: 05 nov. 2024.APA
Brandalise, S. R., Pinheiro, V. R., Aguiar, S. S., Matsuda, E. I., Otubo, R., Yunes, J. A., et al. (2010). Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology, 28( 11), 1911-1918.NLM
Brandalise SR, Pinheiro VR, Aguiar SS, Matsuda EI, Otubo R, Yunes JA, Pereira WA, Carvalho EG, Cristofani LM, Souza MS, Lee ML, Dobbin JA, Pombo-de-Oliveira MS, Lopes LF, Melnikoff KNT, Brunetto AL, Tone LG, Scrideli CA, Morais VLL, Viana MB. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology. 2010 ; 28( 11): 1911-1918.[citado 2024 nov. 05 ]Vancouver
Brandalise SR, Pinheiro VR, Aguiar SS, Matsuda EI, Otubo R, Yunes JA, Pereira WA, Carvalho EG, Cristofani LM, Souza MS, Lee ML, Dobbin JA, Pombo-de-Oliveira MS, Lopes LF, Melnikoff KNT, Brunetto AL, Tone LG, Scrideli CA, Morais VLL, Viana MB. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group-Protocol ALL-99. Journal of Clinical Oncology. 2010 ; 28( 11): 1911-1918.[citado 2024 nov. 05 ]